Dr. Reddy's Gets DCGI Approval for Zytorvi (Toripalimab) to Treat Advanced Esophageal Cancer
Dr. Reddy's Laboratories has been granted approval by the Drugs Controller General of India (DCGI) for Zytorvi (toripalimab) in India. The drug is meant for patients with advanced esophageal squamous cell carcinoma (ESCC...